These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 34974650)

  • 1. Association between serum osteoprotegerin level and renal prognosis in nondialysis patients with chronic kidney disease in the Korean Cohort Study for Outcomes in Patients with Chronic Kidney Disease (the KNOW-CKD Study).
    Oh TR; Myeong C; Song SH; Choi HS; Suh SH; Kim CS; Bae EH; Chung W; Choi KH; Oh KH; Ma SK; Kim SW
    Kidney Res Clin Pract; 2022 Mar; 41(2):200-208. PubMed ID: 34974650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular calcification in patients with nondialysis CKD over 3 years.
    Górriz JL; Molina P; Cerverón MJ; Vila R; Bover J; Nieto J; Barril G; Martínez-Castelao A; Fernández E; Escudero V; Piñera C; Adragao T; Navarro-Gonzalez JF; Molinero LM; Castro-Alonso C; Pallardó LM; Jamal SA
    Clin J Am Soc Nephrol; 2015 Apr; 10(4):654-66. PubMed ID: 25770175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum triglycerides level is independently associated with renal outcomes in patients with non-dialysis chronic kidney disease: Results from KNOW-CKD study.
    Suh SH; Oh TR; Choi HS; Kim CS; Bae EH; Oh KH; Han SH; Ma SK; Kim SW
    Front Nutr; 2022; 9():1037618. PubMed ID: 36505239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Serum Osteoprotegerin Levels with Bone Loss in Chronic Kidney Disease: Insights from the KNOW-CKD Study.
    Kim CS; Bae EH; Ma SK; Han SH; Choi KH; Lee J; Chae DW; Oh KH; Ahn C; Kim SW;
    PLoS One; 2016; 11(11):e0166792. PubMed ID: 27855207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperuricemia has increased the risk of progression of chronic kidney disease: propensity score matching analysis from the KNOW-CKD study.
    Oh TR; Choi HS; Kim CS; Bae EH; Ma SK; Sung SA; Kim YS; Oh KH; Ahn C; Kim SW
    Sci Rep; 2019 Apr; 9(1):6681. PubMed ID: 31040373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary Angiotensinogen and Progression of Chronic Kidney Disease: Results from KNOW-CKD Study.
    Suh SH; Oh TR; Choi HS; Yang EM; Kim CS; Bae EH; Ma SK; Oh KH; Jung JY; Hyun YY; Kim SW
    Biomolecules; 2022 Sep; 12(9):. PubMed ID: 36139118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum osteoprotegerin measurement for early diagnosis of chronic kidney disease-mineral and bone disorder.
    Jiang JQ; Lin S; Xu PC; Zheng ZF; Jia JY
    Nephrology (Carlton); 2011 Aug; 16(6):588-94. PubMed ID: 21649792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High serum adiponectin as a biomarker of renal dysfunction: Results from the KNOW-CKD study.
    Song SH; Oh TR; Choi HS; Kim CS; Ma SK; Oh KH; Ahn C; Kim SW; Bae EH
    Sci Rep; 2020 Mar; 10(1):5598. PubMed ID: 32221363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Serum Ig Free Light Chains with Mortality and ESRD among Patients with Nondialysis-Dependent CKD.
    Ritchie J; Assi LK; Burmeister A; Hoefield R; Cockwell P; Kalra PA
    Clin J Am Soc Nephrol; 2015 May; 10(5):740-9. PubMed ID: 25825483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal Hypoxia: An Important Prognostic Marker in Patients with Chronic Kidney Disease.
    Zhou H; Yang M; Jiang Z; Ding J; Di J; Cui L
    Am J Nephrol; 2018; 48(1):46-55. PubMed ID: 30048964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Correlation of Serum Osteoprotegerin with Non-Traditional Cardiovascular Risk Factors and Arterial Stiffness in Patients with Pre-Dialysis Chronic Kidney Disease: Results from the KNOW-CKD Study.
    Chae SY; Chung W; Kim YH; Oh YK; Lee J; Choi KH; Ahn C; Kim YS
    J Korean Med Sci; 2018 Dec; 33(53):e322. PubMed ID: 30595681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association Between Serum High-Density Lipoprotein Cholesterol Levels and Progression of Chronic Kidney Disease: Results From the KNOW-CKD.
    Nam KH; Chang TI; Joo YS; Kim J; Lee S; Lee C; Yun HR; Park JT; Yoo TH; Sung SA; Lee KB; Oh KH; Kim SW; Lee J; Kang SW; Choi KH; Ahn C; Han SH;
    J Am Heart Assoc; 2019 Mar; 8(6):e011162. PubMed ID: 30859896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating osteoprotegerin levels and cardiovascular outcomes in patients with pre-dialysis chronic kidney disease: results from the KNOW-CKD study.
    Suh SH; Oh TR; Choi HS; Kim CS; Bae EH; Ma SK; Oh KH; Lee KB; Jeong JC; Jung JY; Kim SW;
    Sci Rep; 2024 Feb; 14(1):4136. PubMed ID: 38374135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low HDL cholesterol as a predictor of chronic kidney disease progression: a cross-classification approach and matched cohort analysis.
    Kawachi K; Kataoka H; Manabe S; Mochizuki T; Nitta K
    Heart Vessels; 2019 Sep; 34(9):1440-1455. PubMed ID: 30874893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteoprotegerin and sclerostin in chronic kidney disease prior to dialysis: potential partners in vascular calcifications.
    Morena M; Jaussent I; Dupuy AM; Bargnoux AS; Kuster N; Chenine L; Leray-Moragues H; Klouche K; Vernhet H; Canaud B; Cristol JP
    Nephrol Dial Transplant; 2015 Aug; 30(8):1345-56. PubMed ID: 25854266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic acidosis is associated with increased risk of adverse kidney outcomes and mortality in patients with non-dialysis dependent chronic kidney disease: an observational cohort study.
    Tangri N; Reaven NL; Funk SE; Ferguson TW; Collister D; Mathur V
    BMC Nephrol; 2021 May; 22(1):185. PubMed ID: 34011303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Red cell distribution width and renal outcome in patients with non-dialysis-dependent chronic kidney disease.
    Yonemoto S; Hamano T; Fujii N; Shimada K; Yamaguchi S; Matsumoto A; Kubota K; Hashimoto N; Oka T; Senda M; Sakaguchi Y; Matsui I; Isaka Y
    PLoS One; 2018; 13(6):e0198825. PubMed ID: 29889895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sclerostin and osteoprotegerin: new markers of chronic kidney disease mediated mineral and bone disease in children.
    Guven S; Gokce I; Cicek N; Yaman A; Vatansever P; Alpay H
    J Pediatr Endocrinol Metab; 2020 Nov; 33(11):1383-1390. PubMed ID: 33068383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of blood urea nitrogen independent of the estimated glomerular filtration rate on the development of anemia in non-dialysis chronic kidney disease: The results of the KNOW-CKD study.
    Kim HJ; Kim TE; Han M; Yi Y; Jeong JC; Chin HJ; Song SH; Lee J; Lee KB; Sung S; Han SH; Seong EY; Ahn C; Oh KH; Chae DW
    PLoS One; 2021; 16(9):e0257305. PubMed ID: 34506574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FGF-23 and Osteoprotegerin but not Fetuin-A are associated with death and enhance risk prediction in non-dialysis chronic kidney disease stages 3-5.
    Alderson HV; Ritchie JP; Middleton R; Larsson A; Larsson TE; Kalra PA
    Nephrology (Carlton); 2016 Jul; 21(7):566-73. PubMed ID: 27334353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.